Signature Estate & Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,371
Closed -$143K 172
2017
Q4
$143K Sell
1,371
-127,512
-99% -$14.4M 0.01% 146
2017
Q3
$18.8M Buy
128,883
+1,385
+1% +$189K 2.1% 12
2017
Q2
$16.6M Buy
127,498
+7,092
+6% +$869K 1.96% 18
2017
Q1
$15M Buy
120,406
+6,671
+6% +$798K 1.87% 20
2016
Q4
$13.2M Buy
+113,735
New +$12.7M 1.83% 22

Other funds holding CELG

Signature Estate & Investment Advisors's CELG Position: Q1 2018 in Review

Signature Estate & Investment Advisors sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 1,371 shares — an estimated $143K sold.

Signature Estate & Investment Advisors first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $18.8M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Signature Estate & Investment Advisors reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 1,371 Celgene Corp shares in Q1 2018, an estimated $143K.
  • Signature Estate & Investment Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • Signature Estate & Investment Advisors's Celgene Corp position peaked at $18.8M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Signature Estate & Investment Advisors's 13F filing for Q1 2018, filed 16 Apr 2018.